<PubmedArticle>
<MedlineCitation IndexingMethod="Curated" Owner="NLM" Status="MEDLINE">
<PMID Version="1">26961964</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0046</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>162</Volume>
<PubDate>
<Year>2016</Year>
<Month>May</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Drug and alcohol dependence</Title>
<ISOAbbreviation>Drug Alcohol Depend</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls.</ArticleTitle>
<Pagination>
<MedlinePgn>56-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drugalcdep.2016.02.021</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0376-8716(16)00096-X</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Deficits in executive function have been associated with risk for relapse. Data from previous studies suggest that relapse may be triggered by stress and drug-paired cues and that there are significant sex differences in the magnitude of these responses. The aim of this study was to examine the impact of the pharmacological stressor and alpha-2 adrenergic receptor antagonist yohimbine and cocaine cues on executive function in cocaine-dependent men and women.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In a double-blind placebo controlled cross-over study, cocaine-dependent men (n=12), cocaine-dependent women (n=27), control men (n=31) and control women (n=25) received either yohimbine or placebo prior to two cocaine cue exposure sessions. Participants performed the Connors' Continuous Performance Test II prior to medication/placebo administration and immediately after each cue exposure session</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Healthy controls had a significant increase in commission errors under the yohimbine condition [RR (95% CI)=1.1 (1.0-1.3), χ(2)1=2.0, p=0.050]. Cocaine-dependent individuals exhibited a significant decrease in omission errors under the yohimbine condition [RR (95% CI)=0.6 (0.4-0.8), χ(2)1=8.6, p=0.003]. Cocaine-dependent women had more omission errors as compared to cocaine-dependent men regardless of treatment [RR (95% CI)=7.2 (3.6-14.7), χ(2)1=30.1, p&lt;0.001]. Cocaine-dependent women exhibited a slower hit reaction time as compared to cocaine-dependent men [Female 354 ± 13 vs. Male 415 ± 14; t89=2.6, p=0.012].</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data add to a growing literature demonstrating significant sex differences in behaviors associated with relapse in cocaine-dependent individuals.</AbstractText>
<CopyrightInformation>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moran-Santa Maria</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, United States. Electronic address: moranm@musc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baker</LastName>
<ForeName>N L</ForeName>
<Initials>NL</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, 29425, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McRae-Clark</LastName>
<ForeName>A L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prisciandaro</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brady</LastName>
<ForeName>K T</ForeName>
<Initials>KT</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, United States; Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC 29401, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23 AA020842</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 DA016511</GrantID>
<Acronym>DA</Acronym>
<Agency>NIDA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000062</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>02</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>Drug Alcohol Depend</MedlineTA>
<NlmUniqueID>7513587</NlmUniqueID>
<ISSNLinking>0376-8716</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>2Y49VWD90Q</RegistryNumber>
<NameOfSubstance UI="D015016">Yohimbine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>I5Y540LHVR</RegistryNumber>
<NameOfSubstance UI="D003042">Cocaine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001288">Attention</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003042">Cocaine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019970">Cocaine-Related Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018592">Cross-Over Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003463">Cues</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004311">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007175">Impulsive Behavior</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012727">Sex Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015016">Yohimbine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cocaine</Keyword>
<Keyword MajorTopicYN="N">Drug-cues</Keyword>
<Keyword MajorTopicYN="N">Executive control</Keyword>
<Keyword MajorTopicYN="N">Sex differences</Keyword>
<Keyword MajorTopicYN="N">Stress</Keyword>
<Keyword MajorTopicYN="N">Yohimbine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>09</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>02</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>02</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>11</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26961964</ArticleId>
<ArticleId IdType="pii">S0376-8716(16)00096-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.drugalcdep.2016.02.021</ArticleId>
<ArticleId IdType="pmc">PMC4833507</ArticleId>
<ArticleId IdType="mid">NIHMS763192</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Subst Abuse Treat. 2001 Sep;21(2):77-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11551736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Addict Behav. 2015 Aug;47:86-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25900705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2002 May 1;66(3):265-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12062461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2002 Sep 15;22(18):7856-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12223538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2002 Oct;159(10):1642-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12359667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Brain Res Rev. 2003 Apr;42(1):33-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12668290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2003 Aug 27;23(21):7839-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12944513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2003 Oct;170(1):62-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12845411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 1983 Jul 4;33(1):19-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6865647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hosp Community Psychiatry. 1994 Jan;45(1):18-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8125454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 1995 Apr;38(1):35-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7648995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9881538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 1999 Jan 1;45(1):26-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9894572</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 1999 Mar;142(4):343-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10229058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatry Res. 2004 Oct 30;128(3):209-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15541777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2004 Dec 8;24(49):11017-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15590917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2005 Mar;30(3):610-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15637640</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Alcohol Clin Exp Res. 2005 Mar;29(3):317-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15770105</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2005 May 15;57(10):1209-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15866563</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2005 Jun 1;57(11):1377-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15950011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Psychophysiol. 2005 Oct;58(1):59-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15950304</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Brain Res. 2006 Nov 1;174(1):1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16920204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2008 Jun 1;95(3):279-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18329188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatry Res. 2008 Aug 15;160(2):145-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18555537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Biochem Behav. 2009 Sep;93(3):331-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19409923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Clin Psychopharmacol. 2009 Oct;17(5):302-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19803629</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Brain Res. 2010 Mar 17;208(1):144-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19931573</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Exp Neuropsychol. 2009 Aug;31(6):706-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19037812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroscience. 2010 May 19;167(3):709-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20219635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Subst Use Misuse. 2011;46(1):23-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21190403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2011 Jan;213(1):19-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20827461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(2):e16573</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21373180</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2011 Jul;216(1):53-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21308466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2012 Apr 1;122(1-2):142-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22018602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2012 Aug;222(4):633-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22374254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroimage. 2012 Oct 1;62(4):2281-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22326834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2013 Sep;229(1):83-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23559222</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Clin Psychopharmacol. 2013 Dec;21(6):475-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24099351</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2014 Oct;231(21):4157-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24710621</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Biochem Behav. 2014 Nov;126:63-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25242808</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychopharmacol. 2015 Mar;29(3):312-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25567555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2002 Jan 1;65(2):115-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11772473</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>